Lv1
70 积分 2024-04-24 加入
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial
3小时前
待确认
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
2个月前
已完结
Biological mechanisms and immunotherapy of brain metastases in non-small cell lung cancer
3个月前
已完结
Opportunities and challenges for non–small cell lung cancer brain metastases in the immunotherapy era
3个月前
已完结
皖公网安备34019202002308
